İyi bir fiyat.  çevrimiçi

Ürün ayrıntıları

Created with Pixso. Evde Created with Pixso. Ürünler Created with Pixso.
Gastrointestinal Kanser Tedavisi
Created with Pixso. Lenvatinib Mesilate Capsules 4mg 30 Capsules Box Multi Kinase TKI for Thyroid Hepatocellular Renal Cell Carcinoma

Lenvatinib Mesilate Capsules 4mg 30 Capsules Box Multi Kinase TKI for Thyroid Hepatocellular Renal Cell Carcinoma

Marka Adı: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Numarası: Lenvatinib KL-20213946
Adedi: Pazarlık edilebilir
fiyat: Please contact a specialist WhatsApp:55342706
Teslimat süresi: Pazarlık edilebilir
Ödeme Koşulları: Western Union, Moneygram, T/T
Detay Bilgisi
Menşe yeri:
Chengdu, Siçuan, Çin
Sertifika:
NMPA/GMP
Ambalaj bilgileri:
Pazarlık edilebilir
Yetenek temini:
Pazarlık edilebilir
Vurgulamak:

Multi Kinase VEGFR TKI

,

Differentiated Thyroid Cancer Therapy

,

HCC RCC Oral Capsule Treatment

Ürün Açıklaması
Lenvatinib Mesilate 4mg x 30 Capsules [Product Name] Generic Name: Lenvatinib Mesilate Brand Name: Lundaxin Specification: 4mg x 30 Capsules [Active Ingredient] Lenvatinib Mesilate [Indications] 1. Radioactive iodine-refractory differentiated thyroid cancer. 2. First-line unresectable HCC. 3. Advanced RCC with everolimus. [Mechanism of Action] Multi-targeted TKI inhibiting VEGFR1-3, FGFR1-4, PDGFRa, c-KIT, RET. Dual anti-angiogenic and direct antitumor activity. [Dosage and